347 related articles for article (PubMed ID: 35027028)
1. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
[TBL] [Abstract][Full Text] [Related]
2. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
[TBL] [Abstract][Full Text] [Related]
4. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.
Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X
Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478
[TBL] [Abstract][Full Text] [Related]
5. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
Front Immunol; 2018; 9():876. PubMed ID: 29740454
[TBL] [Abstract][Full Text] [Related]
6. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease.
Castellanos-Moreira R; Rodríguez-García SC; Gomara MJ; Ruiz-Esquide V; Cuervo A; Casafont-Solé I; Ramírez J; Holgado S; Gómez-Puerta JA; Cañete JD; Haro I; Sanmarti R
Ann Rheum Dis; 2020 May; 79(5):587-594. PubMed ID: 32156708
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M
Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956
[TBL] [Abstract][Full Text] [Related]
8. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
[TBL] [Abstract][Full Text] [Related]
10. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
[TBL] [Abstract][Full Text] [Related]
11. Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis.
Roos Ljungberg K; Joshua V; Skogh T; Eklund A; Sköld CM; Karimi R; Nyrén S; Svärd A; Catrina AI; Kastbom A
Rheumatology (Oxford); 2020 Apr; 59(4):852-859. PubMed ID: 31504962
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
Front Immunol; 2021; 12():627986. PubMed ID: 34093522
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans.
Natalini JG; Baker JF; Singh N; Mahajan TD; Roul P; Thiele GM; Sauer BC; Johnson CR; Kawut SM; Mikuls TR; England BR
Ann Am Thorac Soc; 2021 Apr; 18(4):598-605. PubMed ID: 33026891
[No Abstract] [Full Text] [Related]
15. [Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease].
Zhu H; Zhao LJ; Zhou Y; Chen Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1003-1007. PubMed ID: 31848494
[TBL] [Abstract][Full Text] [Related]
16. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
[TBL] [Abstract][Full Text] [Related]
17. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical characteristics of symptomatic diffuse interstitial lung disease in rheumatoid arthritis in a Spanish population.
Bonilla Hernán MG; Gómez-Carrera L; Fernández-Velilla Peña M; Álvarez-Sala Walther R; Balsa A
Rev Clin Esp (Barc); 2022 May; 222(5):281-287. PubMed ID: 34583914
[TBL] [Abstract][Full Text] [Related]
20. Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
Roos Ljungberg K; Martinsson K; Wetterö J; Svärd A; Kastbom A
Clin Exp Immunol; 2021 Jun; 204(3):344-351. PubMed ID: 33675063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
